Search Results 1-10 of 16997 for intestinal metaplasia

  1. Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD - Mayo Clinic

    Mayo Clinic researchers have previously demonstrated that both ER approaches yield comparable rates of complete remission of intestinal metaplasia (CRIM).

  2. Gastrointestinal Neoplasia Clinic - Overview

    Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

  3. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

    That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

  4. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD. Endoscopic ...

  5. Barrett's esophagus - Symptoms and causes - Mayo Clinic

    Between the esophagus and the stomach is a critically important valve, the lower esophageal sphincter (LES). Over time, the LES may begin to fail, leading to ...

  6. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

    Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...

  7. Digestive Diseases Resource Center - Medical Professionals - Mayo Clinic

    Update on therapeutic endoscopic ultrasound · Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after ...

  8. Stomach cancer - Symptoms and causes - Mayo Clinic

    Nearly all cancers that start in the stomach are adenocarcinoma stomach cancers. ... Intestinal Metaplasia: What do you do to lower the risk of cancer? 105 ...

  9. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

    ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

  10. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...